You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

4 Results
Drug
Mar 2021
Drug
Other Name(s): Zolinza®
Jun 2019
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Intent: Palliative
Jun 2019
Guidelines and Advice
Status: Current
ID: ES 30-1
Mar 2021